Dark Forest Capital Management’s Axsome Therapeutics AXSM Stock Holding History

Dark Forest Capital Management’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$319K	Buy	+1,304	New	+$283K	0.02%	724
2025 Q4	–	Sell	-7,267	Closed	-$883K	–	977
2025 Q3	$883K	Sell	7,267 -9,624	-57%	-$1.08M	0.03%	785
2025 Q2	$1.76M	Buy	+16,891	New	+$1.79M	0.07%	502
2023 Q2	–	Sell	-825	Closed	-$50.9K	–	1047
2023 Q1	$50.9K	Buy	+825	New	+$54.2K	0.01%	834
2022 Q1	–	Sell	-141	Closed	-$5K	–	1280
2021 Q4	$5K	Buy	+141	New	+$5.19K	﹤0.01%	1143

Other funds holding AXSM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Dark Forest Capital Management's AXSM Position: Q2 2026 in Review

Dark Forest Capital Management opened a new position in Axsome Therapeutics (AXSM) in Q2 2026: 1,304 shares worth $319K. The stake represents 0.02% of the portfolio and ranks #724 among its holdings. This is a return to the name: Dark Forest Capital Management previously reported a position in AXSM as recently as Q3 2025.

Dark Forest Capital Management first reported a position in AXSM in Q4 2021 and has held it in 5 quarters since. The position peaked at $1.76M in Q2 2025. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

Dark Forest Capital Management held 1,304 shares of Axsome Therapeutics worth $319K as of Q2 2026.
Axsome Therapeutics was a new Dark Forest Capital Management position in Q2 2026.
Axsome Therapeutics made up 0.02% of Dark Forest Capital Management's portfolio in Q2 2026, its #724 holding.
Dark Forest Capital Management first reported a position in Axsome Therapeutics in Q4 2021 and has held it in 5 quarters since.
Dark Forest Capital Management's Axsome Therapeutics position peaked at $1.76M in Q2 2025.
506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Dark Forest Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.